Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious dise... Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500 which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Tonix's rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. Show more
New patent expected to expire in 2030 Tosymra® (sumatriptan nasal spray) 10mg is indicated and marketed for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 19, 2024 (GLOBE...
The World Health Organization (WHO) released its preferred target product profile (TPP) criteria for mpox vaccines at its Mpox Research and Innovation Scientific Conference held August 29-30...
Thomas brings more than 20 years of commercial and operations experience in the biopharmaceutical industry to Tonix Tonix is on track to submit an NDA for TNX-102 SL for fibromyalgia in October...
TNX-801 vaccination demonstrated efficacy in protecting animals from lethal challenge with clade I monkeypox and is in development as an mpox vaccine New data show improved tolerability in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0023 | -1.49544863459 | 0.1538 | 0.1675 | 0.137019 | 13418625 | 0.15262963 | CS |
4 | -0.2322 | -60.516028147 | 0.3837 | 0.46 | 0.1313 | 38344296 | 0.23965812 | CS |
12 | -0.4685 | -75.564516129 | 0.62 | 0.95 | 0.1313 | 22404714 | 0.33644165 | CS |
26 | -11.0325 | -98.6453862661 | 11.184 | 11.9328 | 0.1313 | 11809451 | 1.02668922 | CS |
52 | -28.0821 | -99.4634053043 | 28.2336 | 28.3168 | 0.1313 | 6511711 | 2.09801086 | CS |
156 | -120.2885 | -99.8742112255 | 120.44 | 958 | 0.1313 | 8809843 | 93.5706 | CS |
260 | -1019.8485 | -99.9851470588 | 1020 | 1020 | 0.1313 | 10846153 | 157.10045845 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.